open access
Immunophenotypic profiles of peripheral blood lymphocytes on the day of embryo transfer in women undergoing in vitro fertilization.
open access
Abstract
MATERIALS AND METHODS
women were divided into three groups: (1) control fertile group (n=18), (2) infertile women that achieved (n=32), and (3) did not achieve a pregnancy after ICSI (n=26). The following types of leukocytes were analyzed by three-colour flow cytometry by detection of specific CD antigens: lymphocytes T (CD3+), B (CD19+ and CD5+CD19+), T and B (CD5+), NK cells (CD56+CD16-, CD56-CD16+, CD56+CD16+, CD56brightCD16-, CD56dimCD16+). Additionally, the antigen of early activation (CD69) was evaluated on T, B and NK cells. The results were presented as a percentage and total counts of all lymphocytes.
RESULTS
The percentage of total NK cells (CD56+CD16+, CD56+CD16- and CD56-CD16+) did not differ between pregnant and non pregnant women and was lower comparing to control group. Fractions of CD56-CD16+ cells were higher in pregnant vs. non-pregnant women. The percentages of CD56brightCD16- NK cells were higher in control group comparing to both ICSI treated groups. Other fractions of lymphocyte subpopulations, including activated cells (with CD69 expression) did not differ between the analyzed groups. Total counts of CD56-CD16+ cells were higher in pregnant vs. non-pregnant group, and the CD56brightCD16- cells was more abundant in control group vs. women with unsuccessful ICSI.
CONCLUSIONS
Testing of peripheral blood NK cells and the others lymphocytes has limited value as a prognostic factor in ICSI treated patients. The antigen of early lymphocytic activation (CD69) has not any predictive value in prognosis of ICSI outcome.
Abstract
MATERIALS AND METHODS
women were divided into three groups: (1) control fertile group (n=18), (2) infertile women that achieved (n=32), and (3) did not achieve a pregnancy after ICSI (n=26). The following types of leukocytes were analyzed by three-colour flow cytometry by detection of specific CD antigens: lymphocytes T (CD3+), B (CD19+ and CD5+CD19+), T and B (CD5+), NK cells (CD56+CD16-, CD56-CD16+, CD56+CD16+, CD56brightCD16-, CD56dimCD16+). Additionally, the antigen of early activation (CD69) was evaluated on T, B and NK cells. The results were presented as a percentage and total counts of all lymphocytes.
RESULTS
The percentage of total NK cells (CD56+CD16+, CD56+CD16- and CD56-CD16+) did not differ between pregnant and non pregnant women and was lower comparing to control group. Fractions of CD56-CD16+ cells were higher in pregnant vs. non-pregnant women. The percentages of CD56brightCD16- NK cells were higher in control group comparing to both ICSI treated groups. Other fractions of lymphocyte subpopulations, including activated cells (with CD69 expression) did not differ between the analyzed groups. Total counts of CD56-CD16+ cells were higher in pregnant vs. non-pregnant group, and the CD56brightCD16- cells was more abundant in control group vs. women with unsuccessful ICSI.
CONCLUSIONS
Testing of peripheral blood NK cells and the others lymphocytes has limited value as a prognostic factor in ICSI treated patients. The antigen of early lymphocytic activation (CD69) has not any predictive value in prognosis of ICSI outcome.
Title
Immunophenotypic profiles of peripheral blood lymphocytes on the day of embryo transfer in women undergoing in vitro fertilization.
Journal
Folia Histochemica et Cytobiologica
Issue
Article type
Original paper
Pages
73-77
Published online
2008-04-15
Page views
1144
Article views/downloads
2655
Authors
Tomasz Baczkowski
Rafał Kurzawa